The complex molecular epileptogenesis landscape of glioblastoma

Victoria Soeung1, Ralph B Puchalski2, Jeffrey L Noebels3

  • 1Developmental Neurogenetics Laboratory, Department of Neurology, Baylor College of Medicine, Houston, TX, USA.

Cell Reports. Medicine
|August 21, 2024
PubMed

Insights

Glioblastoma tumors disrupt brain excitability, leading to seizures. Specific epilepsy gene patterns at the tumor edge explain why some patients develop seizures and others don't.

Area of Science:

  • Neuroscience
  • Oncology
  • Genetics

Background:

  • Malignant glioblastoma creates a cortical microenvironment promoting hyperexcitability, tumor growth, and immune evasion.
  • Factors like neosynaptogenesis, excess glutamate, and altered membrane currents contribute to excitability imbalances, but only half of glioblastoma cases develop seizures.

Purpose of the Study:

  • To investigate the role of epilepsy genes in the glioblastoma microenvironment and their correlation with seizure development.
  • To understand the genetic basis of peritumoral hyperexcitability and epileptogenesis in glioblastoma patients.

Main Methods:

  • Analysis of spatial contours and expression of 358 validated human epilepsy genes in glioblastoma transcriptomes.
  • Comparison with non-tumor adult and developing cortex gene expression datasets.

Main Results:

  • Approximately half of the studied epilepsy genes, including dosage-sensitive genes linked to monogenic epilepsy, were significantly enriched and aberrantly regulated at the leading edge of glioblastoma.
  • These findings suggest a complex genetic basis for seizures in the vicinity of brain tumors.

Conclusions:

  • Aberrant expression of epilepsy genes in the glioblastoma microenvironment contributes to peritumoral hyperexcitability and epileptogenesis.
  • This genetic dysregulation may explain the variable occurrence of seizures in glioblastoma patients and the limited efficacy of current treatments.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...